Medicare Enrolled

Dr. Husam Alkhersam, M.D.

Neurology · Bedford, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1604 HOSPITAL PKWY STE 200, Bedford, TX 76022
8178484485
In practice since 2005 (20 years)
NPI: 1336124429 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alkhersam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alkhersam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alkhersam

Dr. Husam Alkhersam is a neurology in Bedford, TX, with 20 years in practice. Based on federal Medicare data, Dr. Alkhersam performed 7,328 Medicare services across 694 unique beneficiaries.

Between the years covered by Open Payments, Dr. Alkhersam received a total of $12,301 from 62 pharmaceutical and/or device companies across 422 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alkhersam is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 11% volume in TX$ $12,301 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,328
Medicare services
Top 11% in TX for neurology
694
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~366 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit6,501$5$15
Office visit, established patient (30-39 min)330$88$323
New patient office visit (45-59 min)157$114$500
Office visit, established patient (20-29 min)121$63$218
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face34$100$447
New patient office visit (30-44 min)28$80$325
New patient office visit, complex (60-74 min)28$154$622
Needle measurement of electrical activity in arm or leg muscles, complete study24$75$278
Sleep study in sleep lab (6 years or older)22$92$312
Sleep study in sleep lab with continuous airway pressure (6 years or older)22$91$325
Office visit, established patient, complex (40-54 min)21$127$435
EEG, extended monitoring17$326$1,026
Nerve conduction, 5-6 studies12$102$424
Nerve conduction, 9-10 studies11$166$708
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,301
Total received (2018-2024)
Avg $1,757/year across 7 years
Top 24% in TX for neurology
62
Companies
422
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,298 (59.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,003 (40.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,448
2023
$1,798
2022
$1,318
2021
$73
2020
$5,042
2019
$1,191
2018
$1,430

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Allergan, Inc.
$4,845
ABBVIE INC.
$771
AbbVie Inc.
$622
Teva Pharmaceuticals USA, Inc.
$529
UCB, Inc.
$423
Genentech USA, Inc.
$390
Biogen, Inc.
$310
PFIZER INC.
$299
EMD Serono, Inc.
$258
Biohaven Pharmaceutical Holding Company Ltd.
$248
Sunovion Pharmaceuticals Inc.
$238
GENZYME CORPORATION
$227
Amgen Inc.
$211
Supernus Pharmaceuticals, Inc.
$209
Allergan Inc.
$171
ACADIA Pharmaceuticals Inc
$139
CSL Behring
$139
Novartis Pharmaceuticals Corporation
$137
SK Life Science, Inc.
$132
Philips Electronics North America Corporation
$121
Jazz Pharmaceuticals Inc.
$114
Octapharma USA, Inc.
$111
Lilly USA, LLC
$102
Akcea Therapeutics, Inc.
$96
Amneal Pharmaceuticals LLC
$88
Mallinckrodt Hospital Products Inc.
$85
Neurocrine Biosciences, Inc.
$84
Sumitomo Pharma America, Inc.
$81
JAZZ PHARMACEUTICALS INC.
$75
HARMONY BIOSCIENCES LLC
$70
Medtronic USA, Inc.
$61
Takeda Pharmaceuticals U.S.A., Inc.
$60
US WorldMeds, LLC
$57
Merz North America, Inc.
$54
TG Therapeutics, Inc.
$52
Egalet US Inc
$51
Acorda Therapeutics, Inc
$47
Kyowa Kirin, Inc.
$41
Collegium Pharmaceutical, Inc.
$40
Abbott Laboratories
$40
GE HEALTHCARE
$38
Horizon Therapeutics plc
$35
Upsher-Smith Laboratories LLC
$34
Eisai Inc.
$32
Boston Scientific Corporation
$30
Mallinckrodt Enterprises LLC
$29
Harmony Biosciences LLC
$25
Avion Pharmaceuticals
$25
Inspire Medical Systems, Inc.
$21
Promius Pharma LLC
$20
IMPEL PHARMACEUTICALS INC.
$19
Neurelis, Inc.
$18
LivaNova USA, Inc.
$17
Otsuka America Pharmaceutical, Inc.
$17
Nevro Corp.
$16
ARGENX US, INC.
$15
GE Healthcare
$15
Impax Laboratories, Inc.
$14
GE HealthCare
$13
Arbor Pharmaceuticals, Inc.
$13
Assertio Therapeutics, Inc.
$12
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 50.7% of total payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Actemra · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · DUOPA · Dhivy · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Fintepla · Fycompa · GILENYA · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INSPIRE · KESIMPTA · LEADPOINT · LEMTRADA · LEQEMBI · LYRICA · Leqembi · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NOURIANZ · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS 50MG CAPSULES 30 · Ocrevus · PANZYGA · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Rebif · SPRIX · SUNOSI · Senza · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · Trilogy 100 · Trudhesa · UBRELVY · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · XEOMIN · XYWAV · Xyrem · ZEVO · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (59%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $168 per 100 Medicare services performed
Looking for a neurology in Bedford?
Compare neurologys in the Bedford area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
238
Per 100K population
11.1
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HURST-EULESS-BEDFORD
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Alkhersam is a mixed practice specialist, with above-average Medicare volume (top 11% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Alkhersam experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Alkhersam performed 6,501 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alkhersam receive payments from pharmaceutical companies?
Yes. Dr. Alkhersam received a total of $12,301 from 62 companies across 422 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alkhersam's costs compare to other neurologys in Bedford?
Dr. Alkhersam's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alkhersam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →